Literature DB >> 8253529

Normal breast epithelial cells produce interleukins 6 and 8 together with tumor-necrosis factor: defective IL6 expression in mammary carcinoma.

F Basolo1, P G Conaldi, L Fiore, S Calvo, A Toniolo.   

Abstract

Virtually pure primary cultures of normal mammary epithelial cells (MEC) obtained from healthy women were shown to release interleukin 6 and 8 (IL6, IL8) and to produce a nonsecreted form of tumor-necrosis factor (TNF). No interferon (IFN), whether alpha, beta, or gamma, or IL1-alpha or -beta could be detected. Analysis of cellular RNA confirmed these findings and showed that MEC also express IL6 receptor and TNF-alpha-related mRNAs. Epithelial cells were selectively stained by antibodies to IL6, IL8 and TNF-alpha both in primary cultures and in the normal mammary gland. Samples of human milk contained sizable amounts of IL6, IL8 and IFN-gamma; yet the liquid phase was consistently negative for other cytokines (i.e., TNF-alpha, IFN-alpha/-beta, IL1-alpha/-beta). Expression of IL6 (but not of IL8 and TNF-alpha) was abolished in ductal infiltrating carcinomas and greatly reduced in cultures of oncogene-transfected mammary cells, suggesting that alterations of IL6 expression are associated with pathogenesis in breast cancer.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8253529     DOI: 10.1002/ijc.2910550609

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  24 in total

1.  Cytokine production by human milk cells and peripheral blood mononuclear cells from the same mothers.

Authors:  Joanna S Hawkes; Dani-Louise Bryan; Robert A Gibson
Journal:  J Clin Immunol       Date:  2002-11       Impact factor: 8.317

2.  Interleukin 6 G-174 C polymorphism and breast cancer risk.

Authors:  A M González-Zuloeta Ladd; A Arias Vásquez; J Witteman; A G Uitterlinden; J W Coebergh; A Hofman; B H Ch Stricker; C M van Duijn
Journal:  Eur J Epidemiol       Date:  2006-05-23       Impact factor: 8.082

3.  Inducible and constitutive in vitro neutrophil chemokine expression by mammary epithelial and myoepithelial cells.

Authors:  M R Barber; A G Pantschenko; L S Hinckley; T J Yang
Journal:  Clin Diagn Lab Immunol       Date:  1999-11

4.  Complement fragment C5a and inflammatory cytokines in neutrophil recruitment during intramammary infection with Escherichia coli.

Authors:  D E Shuster; M E Kehrli; P Rainard; M Paape
Journal:  Infect Immun       Date:  1997-08       Impact factor: 3.441

5.  The Tumor-Promoting Flow of Cells Into, Within and Out of the Tumor Site: Regulation by the Inflammatory Axis of TNFα and Chemokines.

Authors:  Adit Ben-Baruch
Journal:  Cancer Microenviron       Date:  2011-12-22

Review 6.  Chemokines: novel targets for breast cancer metastasis.

Authors:  Simi Ali; Gwendal Lazennec
Journal:  Cancer Metastasis Rev       Date:  2007-12       Impact factor: 9.264

7.  Tumor-induced STAT3 signaling in myeloid cells impairs dendritic cell generation by decreasing PKCβII abundance.

Authors:  Matthew R Farren; Louise M Carlson; Colleen S Netherby; Inna Lindner; Pui-Kai Li; Dmitry I Gabrilovich; Scott I Abrams; Kelvin P Lee
Journal:  Sci Signal       Date:  2014-02-18       Impact factor: 8.192

8.  The effects of probiotic supplementation on the gene expressions of immune cell surface markers and levels of antibodies and pro-inflammatory cytokines in human milk.

Authors:  Veronique Demers-Mathieu; Gabrielle B Mathijssen; Ciera DaPra; Elena Medo
Journal:  J Perinatol       Date:  2020-11-18       Impact factor: 2.521

9.  Expression of cytokine and chemokine genes by human middle ear epithelial cells induced by influenza A virus and Streptococcus pneumoniae opacity variants.

Authors:  H H Tong; J P Long; P A Shannon; T F DeMaria
Journal:  Infect Immun       Date:  2003-08       Impact factor: 3.441

10.  Co-expression of interleukin-6 (IL-6) and interleukin-6 receptor (IL-6R) in thyroid nodules is associated with co-expression of CD30 ligand/CD30 receptor.

Authors:  R M Ruggeri; D Villari; A Simone; R Scarfi; M Attard; F Orlandi; G Barresi; F Trimarchi; M Trovato; S Benvenga
Journal:  J Endocrinol Invest       Date:  2002-12       Impact factor: 4.256

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.